rs149782619

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong

The ENST00000304043.10(HINT1):​c.110G>C​(p.Arg37Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,613,686 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R37Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

HINT1
ENST00000304043.10 missense, splice_region

Scores

3
4
12
Splicing: ADA: 0.0001172
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:14

Conservation

PhyloP100: 0.185
Variant links:
Genes affected
HINT1 (HGNC:4912): (histidine triad nucleotide binding protein 1) This gene encodes a protein that hydrolyzes purine nucleotide phosphoramidates substrates, including AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif. This gene is considered a tumor suppressor gene. In addition, mutations in this gene can cause autosomal recessive neuromyotonia and axonal neuropathy. There are several related pseudogenes on chromosome 7. Several transcript variants have been observed. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a chain Adenosine 5'-monophosphoramidase HINT1 (size 124) in uniprot entity HINT1_HUMAN there are 19 pathogenic changes around while only 0 benign (100%) in ENST00000304043.10
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-131165096-C-G is Pathogenic according to our data. Variant chr5-131165096-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 37312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-131165096-C-G is described in Lovd as [Likely_pathogenic]. Variant chr5-131165096-C-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HINT1NM_005340.7 linkuse as main transcriptc.110G>C p.Arg37Pro missense_variant, splice_region_variant 1/3 ENST00000304043.10 NP_005331.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HINT1ENST00000304043.10 linkuse as main transcriptc.110G>C p.Arg37Pro missense_variant, splice_region_variant 1/31 NM_005340.7 ENSP00000304229 P1

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152206
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000260
AC:
65
AN:
250326
Hom.:
0
AF XY:
0.000310
AC XY:
42
AN XY:
135420
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000893
Gnomad NFE exome
AF:
0.000389
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000212
AC:
310
AN:
1461362
Hom.:
0
Cov.:
32
AF XY:
0.000245
AC XY:
178
AN XY:
727010
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000772
Gnomad4 NFE exome
AF:
0.000235
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152324
Hom.:
0
Cov.:
32
AF XY:
0.000362
AC XY:
27
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00169
Gnomad4 NFE
AF:
0.000426
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000403
Hom.:
0
Bravo
AF:
0.000151
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000247
AC:
30
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive axonal neuropathy with neuromyotonia Pathogenic:10
Pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Genetics and Applied Genomics, University Hospital TübingenNov 14, 2023- -
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 01, 2012- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJun 23, 2023- -
Pathogenic, no assertion criteria providedclinical testingInstitute of Human Genetics, Cologne UniversityApr 25, 2018- -
Pathogenic, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaOct 02, 2019This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PM1,PP2,PP5. -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterAug 02, 2024Criteria applied: PM3_VSTR,PS4_SUP,PM2_SUP -
Pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterSep 06, 2022- -
Pathogenic, criteria provided, single submitterclinical testing3billionFeb 23, 2023The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.030%). Missense changes are a common disease-causing mechanism. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000037312). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 4 similarly affected unrelated individuals (PMID: 22961002, 22961002, 26182879, 27549087). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 29, 2023This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 37 of the HINT1 protein (p.Arg37Pro). This variant is present in population databases (rs149782619, gnomAD 0.09%). This missense change has been observed in individuals with clinical features of distal hereditary motor neuropathy (PMID: 22961002, 25342199, 26182879, 27549087). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 37312). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGM-The observed missense c.110G>C (p.Arg37Pro) variant in HINT1 gene has been reported previously in homozygous and compound heterozygous states in multiple individuals affected with neuromyotonia and axonal neuropathy (Zimon et al., 2012; Laššuthová et al., 2015; Jerath et al., 2015; Laššuthová et al., 2016). It has also been observed to segregate with disease in related individuals. Functional studies demonstrate this variant to cause loss of enzyme function (Zimon et al., 2012). This variant is present with allele frequency of 0.03% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic (multiple submissions). Computational evidence (Polyphen - Benign, SIFT - Tolerated and MutationTaster - Disease causing) predicts conflicting evidence on protein structure and function for this variant. The reference amino acid of p.Arg37Pro in HINT1 is predicted as conserved by PhyloP across 100 vertebrates. The amino acid Arg at position 37 is changed to a Pro changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxDec 19, 2022Published functional studies demonstrate loss of enzyme function in the homozygous state (Zimon et al., 2012); Reported as a founder mutation in the Czech population, accounting for 95% of pathogenic alleles (Lassuthova et al., 2015).; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26182879, 32709422, 22961002, 24918641, 25342199, 26194197, 23043279, 27549087, 29787766, 31787464, 31848916, 34562060, 33726816, 34694653, 33663550) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024HINT1: PM3:Very Strong, PP1:Strong, PM2, PS3:Supporting, BP4 -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsNov 23, 2022The c.110G>C (p.R37P) alteration is located in exon 1 (coding exon 1) of the HINT1 gene. This alteration results from a G to C substitution at nucleotide position 110, causing the arginine (R) at amino acid position 37 to be replaced by a proline (P). Based on data from the Genome Aggregation Database (gnomAD), the HINT1 c.110G>C alteration was observed in 0.03% (85/281,678) of total alleles studied. The p.R37P alteration, one of three founder mutations and considered to be the most common, has been reported in homozygous and compound heterozygous individuals with autosomal recessive axonal neuropathy with neuromyotonia (Zimo, 2012; Laššuthová, 2015; Jerath, 2015; Shchagina, 2020). This amino acid position is poorly conserved in available vertebrate species. Protein contain p.R37P fails to form functional dimers and exists as monomers, which showed significant loss of secondary structure compared to wild type and showed reduced near UV-absorption indicating incorrect or improper folding (Shah, 2018). This alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Peripheral neuropathy Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingKariminejad - Najmabadi Pathology & Genetics CenterJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.87
D;.;.;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.95
D;D;D;T
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.40
T;T;T;T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.2
L;.;.;.
MutationTaster
Benign
0.98
D;D;D;D
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-2.0
N;N;N;N
REVEL
Uncertain
0.56
Sift
Benign
0.095
T;D;T;D
Sift4G
Benign
0.18
T;T;T;D
Polyphen
0.26
B;.;.;.
Vest4
0.62
MVP
0.76
MPC
0.89
ClinPred
0.90
D
GERP RS
-0.94
Varity_R
0.95
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00012
dbscSNV1_RF
Benign
0.094
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149782619; hg19: chr5-130500789; API